Showing results (271-280 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|December 17, 2013
Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patientsS Abgrall, J Le Bel, N Lele, et al.
HIV Clinical Trials|October 23, 2013
Long-term safety study of fosamprenavir-containing regimens in HIV-1-infected patientsRobin Wood, Joseph C Gathe, Naomi Givens, et al.
HIV Clinical Trials|October 23, 2013
Efficacy and safety 48 weeks after switching from efavirenz to rilpivirine using emtricitabine/tenofovir disoproxil fumarate-based single-tablet regimensAnthony M Mills, Calvin Cohen, Edwin Dejesus, et al.
HIV Clinical Trials|October 23, 2013
Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142Jeannie S Huang, Michael D Hughes, Sharon A Riddler, et al.
HIV Clinical Trials|April 30, 2016
Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP SubstudyM Crespo, J Navarro, M Martinez-Rebollar, et al.
HIV Clinical Trials|December 7, 2017
Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infectionChan-Loi Yong, Joseph C Gathe, Gabriele Knecht, et al.
HIV Clinical Trials|July 6, 2016
An observational study on the incidence of tuberculosis among a cohort of HIV infected adults in a setting with low prevalence of tuberculosisKaveh Manavi, James Hodson
HIV Clinical Trials|June 13, 2008
Atazanavir in patients with persistent viral replication despite HAART: results from the French prospective NADIS cohortL Cuzin, P Flandre, P Pugliese, et al.
HIV Clinical Trials|June 13, 2008
Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppressionBrian A Boyle, Dushyantha Jayaweera, Mallory D Witt, et al.
HIV Clinical Trials|June 13, 2008
ABCB1 allele polymorphism is associated with virological efficacy in naïve HIV-infected patients on HAART containing nonboosted PIs but not boosted PIsX de la Tribonnière, F Broly, S Deuffic-Burban, et al.
Pageof 68